SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-109830
Filing Date
2008-05-09
Accepted
2008-05-09 16:27:26
Documents
7
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 419992
2 EXCLUSIVE LICENSE AGREEMENT DATED SEPTEMBER 24, 1986 dex101.htm EX-10.1 122574
3 EXCLUSIVE LICENSE AGREEMENT DATED JULY 1, 1988 dex102.htm EX-10.2 109713
4 MASTER SERVICES AGREEMENT dex103.htm EX-10.3 227784
5 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9456
6 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9365
7 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4598
  Complete submission text file 0001193125-08-109830.txt   904897
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 08818804
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1